Novavax COVID-19 Vaccine—A Possibly Safer Choice but Likely Obsolete
THE MCCULLOUGH REPORT - Un pódcast de Dr. Peter McCullough - Lunes
Categorías:
The technology differs from Pfizer and Moderna’s shots, which were the first ones using messenger RNA technology to receive FDA approval and have resulted in catastrophic rates of injury, disability, and death. In the Novavax clinical trial experience, there were no hospitalizations or deaths due to COVID-19...
